Markéta Pelantová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Markéta Pelantová has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aleksi Sedo
Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic
1 shared publication - Aneta Gandalovičová
Department of Cell Biology, Charles University, Viničná 7, Prague, Czech Republic
1 shared publication Anna Legátová
Laboratory of Cancer Cell Invasion, Department of Cell Biology, BIOCEV, Faculty of Science Charles University Vestec Czech Republic
1 shared publication- Daniel Rösel
Department of Cell Biology, Faculty of Science, Charles University, BIOCEV, Prumyslova
1 shared publication - Elena Garcia‐Borja
Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine Charles University Prague Czech Republic
1 shared publication - Jan Brábek
Department of Cell Biology, Faculty of Science (BIOCEV), Charles University, Průmyslová 595, Vestec u Prahy, 252 42, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 3 August 2024
- Published by Wiley in Brain Pathology
- Vol. 35 (1) , e13294
Microtubule‐associated NAV3 regulates invasive phenotypes in glioblastoma cells
Glioblastomas are aggressive brain tumors for which effective therapy is still lacking, resulting in dismal survival rates. These tumors display significant phenotypic plasticity, harboring diverse cell populations ranging from tumor core cells to dispersed, highly invasive cells. Neuron navigator 3 (NAV3), a microtubule‐associated protein affecting microtubule growth and dynamics, is downregulated in various cancers, including glioblastoma, and has thus been considered a tumor suppressor. In this study, we challenge this designation and unveil distinct expression patterns of NAV3 across different invasion phenotypes. Using glioblastoma cell lines and patient‐derived glioma stem‐like cell cultures, we disclose an upregulation of NAV3 in invading glioblastoma cells, contrasting with its lower expression in cells residing in tumor spheroid cores. Furthermore, we establish an association between low and high NAV3 expression and the amoeboid and mesenchymal invasive phenotype, respectively, and demonstrate that overexpression of NAV3 directly stimulates glioblastoma invasive behavior in both 2D and 3D environments. Consistently, we observed increased NAV3 expression in cells migrating along blood vessels in mouse xenografts. Overall, our results shed light on the role of NAV3 in glioblastoma invasion, providing insights into this lethal aspect of glioblastoma behavior.
- 3 August 2024
- Published by Wiley in Brain Pathology
- Vol. 35 (1) , e13294
Open AccessMicrotubule‐associated NAV3 regulates invasive phenotypes in glioblastoma cells
Glioblastomas are aggressive brain tumors for which effective therapy is still lacking, resulting in dismal survival rates. These tumors display significant phenotypic plasticity, harboring diverse cell populations ranging from tumor core cells to dispersed, highly invasive cells. Neuron navigator 3 (NAV3), a microtubule‐associated protein affecting microtubule growth and dynamics, is downregulated in various cancers, including glioblastoma, and has thus been considered a tumor suppressor. In this study, we challenge this designation and unveil distinct expression patterns of NAV3 across different invasion phenotypes. Using glioblastoma cell lines and patient‐derived glioma stem‐like cell cultures, we disclose an upregulation of NAV3 in invading glioblastoma cells, contrasting with its lower expression in cells residing in tumor spheroid cores. Furthermore, we establish an association between low and high NAV3 expression and the amoeboid and mesenchymal invasive phenotype, respectively, and demonstrate that overexpression of NAV3 directly stimulates glioblastoma invasive behavior in both 2D and 3D environments. Consistently, we observed increased NAV3 expression in cells migrating along blood vessels in mouse xenografts. Overall, our results shed light on the role of NAV3 in glioblastoma invasion, providing insights into this lethal aspect of glioblastoma behavior.